Stock CRDL CARDIOL THERAPEUTICS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Cardiol Therapeutics Inc.

Equities

CRDL

CA14161Y2006

Delayed Toronto S.E.
Other stock markets
 10:47:17 2024-04-30 EDT 		5-day change 1st Jan Change
2.61 CAD +8.30% Intraday chart for Cardiol Therapeutics Inc. +4.42% +136.36%
04-22 HC Wainwright Starts Cardiol Therapeutics With Buy Rating, $9 Price Target MT
04-01 Cardiol Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Evolution of the average Target Price on Cardiol Therapeutics Inc.

Price target over the last 5 years

History of analyst recommendation changes

4e316737649800b26caa38bc30225fc.HsD1FGeXNgz9zDuLwMs2RcYtbJNqqYbmuzjr41opTBA.eJabJDT-RU2ur3nioqwPBqpoKvcs-s6-yFm4k3dgE1dXpJRTVdRhYruufg~25d8090be04355bec77362b59faada9f

Analyst Recommendations on Cardiol Therapeutics Inc.

HC Wainwright Starts Cardiol Therapeutics With Buy Rating, $9 Price Target MT
Canaccord Genuity Adjusts Price Target on Cardiol Therapeutics to $6 From $5, Maintains Buy Rating MT
Cantor Fitzgerald Lowers Price Target to Cardiol Therapeutics to $5 From $6, Maintains Overweight Rating MT
CARDIOL THERAPEUTICS : Raymond James Adjusts Cardiol Therapeutics PT to CA$5 From CA$4.50, Maintains Outperform Rating MT
CARDIOL THERAPEUTICS : Target Increased to $5 at Raymond James MT
CARDIOL THERAPEUTICS : Upgraded to Outperform at Raymond James as First Patient Enrolled in Clinical Trial MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
2.41 CAD
Average target price
4.5 CAD
Spread / Average Target
+86.72%
High Price Target
4.5 CAD
Spread / Highest target
+86.72%
Low Price Target
4.5 CAD
Spread / Lowest Target
+86.72%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Cardiol Therapeutics Inc.

HC Wainwright
Canaccord Genuity
Cantor Fitzgerald
Raymond James

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. CRDL Stock
  4. Consensus Cardiol Therapeutics Inc.